Issue 67 July - August 2015

No easy road to outsmart cancer

Hopes of greatly speeding up the evaluation of new therapies by using tumour response to a short course of neoadjuvant treatment as a surrogate for clinical benefit have proved false and the sooner we recognise that the better. This is the message of the Guest Editorial written by Fatima Cardoso, Director of the Breast Unit at LisbonÂ’s Champalimaud Hospital.

Read More ...
Issue 66 May - June 2015

Our cancer risk is not written in the stars

If Tomasetti and Vogelstein had not used the words “bad luck” in their paper on how ‘variation in cancer risk among tissues can be explained by the number of stem cell divisions’, the media might not have covered the story the way they did. In this interview with The Cancer Letter, Bertram Kramer, head of Cancer Prevention at the US National Cancer Institute, tries to clear up some of the confusion.

Read More ...
Issue 66 May - June 2015

International collaboration and the importance of eubiosia

A shared sense of the value of helping people with incurable cancers achieve lives worth living has driven doctors to collaborate across borders for decades. An oncologist shares his experiences from the Cold War to the present day.

Read More ...
Issue 66 May - June 2015

Teenagers and young adults with cancer - addressing the most important care needs

Getting cancer as a teenager or young adult can severely disrupt an important period of emotional, physical and social transition. Tailoring services to fit the particular needs of this age group can make a huge difference.

Read More ...
Issue 66 May - June 2015

Welcome to the revolution! The changing role of patient advocates within research

Patient advocates believe their input into guiding the research process is key to ensuring the right questions are investigated in the right way. Where itÂ’s been successfully tried, both sides agree there is no going back.

Read More ...